Atara Biotherapeutics (NASDAQ:ATRA) reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Atara Biotherapeutics reported an EPS of $-0.31.
Revenue was up $47.71 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 1.47% increase in the share price the next day.
Here’s a look at Atara Biotherapeutics’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.98 | -0.69 | -0.94 | -0.89 |
| EPS Actual | -0.87 | -0.96 | -0.90 | -0.91 |
| Revenue Estimate | 4.91M | 35.14M | 3.92M | 3.84M |
| Revenue Actual | 7.31M | 7.55M | 5.37M | 3.87M |
To track all earnings releases for Atara Biotherapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
